• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

    0.8530 +0.0030 (+0.35%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,844
    Open 0.8530
    Bid (Size) 0.8305 (500)
    Ask (Size) 0.8509 (100)
    Prev. Close 0.8500
    Today's Range 0.8530 - 0.8530
    52wk Range 0.7362 - 2.610
    Shares Outstanding 140,759,276
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Heron (HRTX) Q4 2025 Earnings Call Transcript ↗
    Heron (HRTX) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    Heron Therapeutics Inc (NASDAQ:HRTX) Reports Q4 2025 Revenue Beat and Positive 2026 Outlook ↗
    Via Chartmill

    Performance

    YTD
    -32.3%
    -32.3%
    1 Month
    -3.3%
    -3.3%
    3 Month
    -42.8%
    -42.8%
    6 Month
    -34.4%
    -34.4%
    1 Year
    -55.8%
    -55.8%

    More News

    Read More
    News headline image
    Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 6, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For February 27, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For November 12, 2024 ↗
    Via Benzinga
    News headline image
    Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates ↗
    Via Chartmill
    News headline image
    Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
    From Heron Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Traders are paying attention to the gapping stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    Heron (HRTX) Q2 Acute Care Jumps 56% ↗
    Via The Motley Fool
    Topics Economy Intellectual Property
    News headline image
    This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    HRTX Stock Earnings: Heron Therapeutics Misses EPS, Beats Revenue for Q2 2024 ↗
    Via InvestorPlace
    News headline image
    Top 3 Health Care Stocks That May Crash In May ↗
    Via Benzinga

    Frequently Asked Questions

    Is Heron Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Heron Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Heron Therapeutics, Inc. - Common Stock trade on?
    Heron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Heron Therapeutics, Inc. - Common Stock?
    The ticker symbol for Heron Therapeutics, Inc. - Common Stock is HRTX on the Nasdaq Stock Market
    What is the current price of Heron Therapeutics, Inc. - Common Stock?
    The current price of Heron Therapeutics, Inc. - Common Stock is 0.8530
    When was Heron Therapeutics, Inc. - Common Stock last traded?
    The last trade of Heron Therapeutics, Inc. - Common Stock was at 04/10/26 04:00 PM ET
    What is the market capitalization of Heron Therapeutics, Inc. - Common Stock?
    The market capitalization of Heron Therapeutics, Inc. - Common Stock is 120.07M
    How many shares of Heron Therapeutics, Inc. - Common Stock are outstanding?
    Heron Therapeutics, Inc. - Common Stock has 120M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.